Viewing Study NCT05132218


Ignite Creation Date: 2025-12-25 @ 4:52 AM
Ignite Modification Date: 2026-01-27 @ 6:16 AM
Study NCT ID: NCT05132218
Status: UNKNOWN
Last Update Posted: 2021-11-24
First Post: 2021-10-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ALK Positive View
None NSCLC Stage IIIB View
None NSCLC Stage IV View
Keywords: